Model card — the label on the model
Drugs ship with labels; the model card is the equivalent for algorithms — intended use, training population, performance claims, limitations, required oversight.
For a governance programme it plays two roles. At intake, it is the vendor’s testimony: the written claims your due-diligence questionnaire pins down and your risk tiering reads. At deployment, it is the null hypothesis: the card says AUROC 0.91 on the vendor’s population; local validation asks what it is on yours. The card that cannot be produced is itself a finding — a vendor unable to state intended use and known limits in one page is telling you something about the diligence to come.
← All RUAIH questions, areas and terms · The complete healthcare AI governance guide · Score your readiness